Back to search
FDAFDA · Food and drugs·Recall number Z-1809-2024

LASER Application Instrument, 23 cm, REF: 8694; LEUNIG-GREVERS LASER Application, REF: 461000

Published May 22, 2024 · Recall initiated: April 1, 2024

Summary

FDA records medical device Class II recall Z-1809-2024, published May 22, 2024 and initiated April 1, 2024. Recalling firm: Karl Storz Endoscopy; Status: Ongoing; Reported quantity: 85; Lot: All lots. REF/UDI-DI: 8694/04048551216392, 461000/04048551164860. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Laser surgical instruments have no specific evidence of a validated reprocessing method, therefore these instruments lack sterility assurance, so once the instruments have gone through reprocessing after use and then are used again, there is an increased risk of the patient being exposed to infection.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Karl Storz Endoscopy
Distributor
Worldwide distribution - US Nationwide in the states of OH, CA, FL, MA, TX, KY, WI, MI, MN, AR, NE, IL, NY, HI and the country of Argentina.
Lot
All lots. REF/UDI-DI: 8694/04048551216392, 461000/04048551164860
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LASER Application Instrument, 23 cm, REF: 8694; LEUNIG-GREVERS LASER Application, REF: 461000 recalled?

Yes. FDA published recall Z-1809-2024 on May 22, 2024. Reported hazard: Laser surgical instruments have no specific evidence of a validated reprocessing method, therefore these instruments lack sterility assurance, so once the instruments have gone through reprocessing after use and then are used again, there is an increased risk of the patient being exposed to infection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter